Yesterday, a Director at Zogenix (ZGNX), Erle Mast, sold shares of ZGNX for $61.76K.
This is Mast’s first Sell trade following 3 Buy transactions.
See today’s analyst top recommended stocks >>
Currently, Zogenix has an average volume of 430.9K.
Based on 6 analyst ratings, the analyst consensus is Strong Buy with an average price target of $75.00, reflecting a 77.9% upside.
The insider sentiment on Zogenix has been positive according to 14 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday.
